Comparing the current results to its competitors, Balchem reported Revenue increase in the 2 quarter 2026 by 11.17 % year on year. The sales growth was above Balchem's competitors' average revenue growth of 1.29 %, achieved in the same quarter.
Balchem Corp Net Income in the 2 quarter 2026 grew year on year by 16.56%, while most of its competitors have experienced a contraction in net income by -35.98 %.
Balchem's Comment on Competition and Industry Peers
The company operates in competitive markets for supplements, food and beverage, animal feed, and industrial products. Competitors range from large to small companies, some possessing greater financial, research and development, and production resources. Competition is based on product performance, customer support, quality, service, and price. Success requires substantial investment in product and manufacturing process research and development, application testing, and sales efforts. In the supplement, food and beverage markets, competitors include various ingredient and nutritional supplement companies, many of which are privately held, making it difficult to determine their size or the company's market ranking. In the animal feed and industrial markets, competition is highly price sensitive and includes animal nutrition and health ingredient companies as well as certain industrial companies, many of which are also privately held.
Company's competitiveness improved within Overall company, with revenue growth of 11.17 % and its market share increased to approx. 0.67 %. << More on BCPC Market Share.
*Market share is calculated based on total revenue.
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.
Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.
Abbott Laboratories operates as a diversified healthcare company with a focus on developing and manufacturing a wide range of health-related products, including pharmaceuticals, medical devices, nutritional products, and diagnostic technologies. Their business model emphasizes innovation and quality, aiming to address the diverse needs of patients and healthcare providers across various sectors globally. By leveraging their expertise and extensive portfolio, Abbott strives to enhance patient outcomes and improve the overall quality of life.
DuPont De Nemours Inc operates as a diversified science and technology company, leveraging advanced materials and innovative solutions to serve multiple industries such as agriculture, electronics, transportation, and healthcare. The companys business model emphasizes sustainability and innovation, aiming to meet the evolving needs of its customers while addressing global challenges.
Sources:
Balchem Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Balchem Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
